{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:28:46Z","timestamp":1793672926691,"version":"4.5.1"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Research Centre Egypt"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Liver fibrosis, a severe health issue linked to liver injury, inflammation, and cell death, often progresses to liver cancer without effective treatments. In this study, an exosome-nanoliposome hybrid loaded with caffeine (Caff) was developed for the management of liver fibrosis. The role of superparamagnetic iron oxide nanoparticles (SPION) in promoting targeted delivery to the liver was also investigated. Caff-loaded liposomes with variable phospholipid and stearylamine molar ratios were prepared and characterized. The formula with optimized characteristics (Caff\/liposomes) selected by Design Expert exhibited a particle size of 179.73\u2009\u00b1\u20093.1\u00a0nm, a polydispersity index of 0.19\u2009\u00b1\u20090.02, an entrapment efficiency of 89.79\u2009\u00b1\u200921%, and a zeta potential of -35.50\u2009\u00b1\u20091.1 mV, and was used to encapsulate SPION. Caff\/SPION liposomes were further loaded into exosomes, isolated from bone marrow-mesenchymal stem cells, and visualized by TEM. The biological experiment was conducted on rats with thioacetamide-induced liver injury to reveal the efficacy of exosome-Caff\/SPION liposome hybrid (F1) in comparison to exosome-Caff\/liposomes (F2) and exosome-SPION\/liposomes (F3). Among all the tested formulations, F1 demonstrated the most promising results regarding liver function markers (ALT and AST), inflammatory molecules (IL-6, IL-10, TLR-4, Myd88, NF-\u03baB), fibrotic protein (\u03b1-SMA), hepatocyte proliferative capacity (PCNA), as well as liver histoarchitecture. This finding suggests that the engineered Caff\/SPION liposome-exosome hybrid can effectively enhance the targeting of the drug and the homing of exosomes to the injured liver, thereby representing a novel strategy for treating liver fibrosis.<\/jats:p>","DOI":"10.1038\/s41598-025-31169-w","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T15:22:57Z","timestamp":1770391377000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of engineered magnetic liposome\/exosome hybrid as a novel caffeine nanocarrier for restraining liver fibrosis induced in rats"],"prefix":"10.1038","volume":"16","author":[{"given":"Yara E.","family":"Elakkad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Refai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa H.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed N.","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menna M.","family":"Abdellatif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola A. M.","family":"Mohawed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rehab S.","family":"Abohashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"31169_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","volume":"79","author":"H Devarbhavi","year":"2023","unstructured":"Devarbhavi, H. et al. Global burden of liver disease: 2023 update. J. Hepatol. 79, 516\u2013537 (2023).","journal-title":"J. Hepatol."},{"key":"31169_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/cld.1061","volume":"17","author":"S Cheemerla","year":"2021","unstructured":"Cheemerla, S. & Balakrishnan, M. Global epidemiology of chronic liver disease. Clin. Liver Disease. 17, 365\u2013370 (2021).","journal-title":"Clin. Liver Disease"},{"key":"31169_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3748\/wjg.v26.i2.109","volume":"26","author":"S Tanwar","year":"2020","unstructured":"Tanwar, S., Rhodes, F., Srivastava, A., Trembling, P. M. & Rosenberg, W. M. Inflammation and fibrosis in chronic liver diseases including nonalcoholic fatty liver disease and hepatitis C. World J. Gastroenterol. 26, 109 (2020).","journal-title":"World J. Gastroenterol."},{"key":"31169_CR4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1080\/14728214.2021.1918099","volume":"26","author":"JA Fallowfield","year":"2021","unstructured":"Fallowfield, J. A., Jimenez-Ramos, M. & Robertson, A. Emerging synthetic drugs for the treatment of liver cirrhosis. Expert Opin. Emerg. Drugs. 26, 149\u2013163 (2021).","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"31169_CR5","doi-asserted-by":"publisher","first-page":"562","DOI":"10.21037\/atm.2020.02.119","volume":"8","author":"Y Cao","year":"2020","unstructured":"Cao, Y., Ji, C. & Lu, L. Mesenchymal stem cell therapy for liver fibrosis\/cirrhosis. Ann. Transl Med. 8, 562 (2020).","journal-title":"Ann. Transl Med."},{"key":"31169_CR6","doi-asserted-by":"publisher","first-page":"5310202","DOI":"10.1155\/2019\/5310202","volume":"2019","author":"K Yuan","year":"2019","unstructured":"Yuan, K. et al. The effect of vascular endothelial growth factor on bone marrow mesenchymal stem cell engraftment in rat fibrotic liver upon transplantation. Stem Cells Int. 2019, 5310202 (2019).","journal-title":"Stem Cells Int."},{"key":"31169_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s00535-021-01765-4","volume":"56","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Emerging role and therapeutic application of exosome in hepatitis virus infection and associated diseases. J. Gastroenterol. 56, 336\u2013349 (2021).","journal-title":"J. Gastroenterol."},{"key":"31169_CR8","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Y\u00e1\u00f1ez-M\u00f3","year":"2015","unstructured":"Y\u00e1\u00f1ez-M\u00f3, M. et al. Biological properties of extracellular vesicles and their physiological functions. J. Extracell. Vesicles. 4, 27066 (2015).","journal-title":"J. Extracell. Vesicles"},{"key":"31169_CR9","doi-asserted-by":"publisher","first-page":"590470","DOI":"10.3389\/fphar.2020.590470","volume":"11","author":"W Wei","year":"2021","unstructured":"Wei, W. et al. Mesenchymal stem cell\u2013derived exosomes: a promising biological tool in nanomedicine. Front. Pharmacol. 11, 590470 (2021).","journal-title":"Front. Pharmacol."},{"key":"31169_CR10","doi-asserted-by":"publisher","first-page":"878058","DOI":"10.3389\/fphar.2022.878058","volume":"13","author":"S Ghosh","year":"2022","unstructured":"Ghosh, S., Ghosh, S. & Exosome The Off-the-Shelf cellular nanocomponent as a potential pathogenic Agent, a disease Biomarker, and neurotherapeutics. Front. Pharmacol. 13, 878058 (2022).","journal-title":"Front. Pharmacol."},{"key":"31169_CR11","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jconrel.2019.02.032","volume":"299","author":"F Hosseini Shamili","year":"2019","unstructured":"Hosseini Shamili, F. et al. Immunomodulatory properties of MSC-derived exosomes armed with high affinity aptamer toward Mylein as a platform for reducing multiple sclerosis clinical score. J. Controlled Release. 299, 149\u2013164 (2019).","journal-title":"J. Controlled Release"},{"key":"31169_CR12","first-page":"1695802","volume":"2022","author":"C Wang","year":"2022","unstructured":"Wang, C., Liu, J., Yan, Y. & Tan, Y. Role of exosomes in chronic liver disease development and their potential clinical applications. J. Immunol. Res. 2022, 1695802 (2022).","journal-title":"J. Immunol. Res."},{"key":"31169_CR13","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12951-023-01788-4","volume":"21","author":"Z Zhang","year":"2023","unstructured":"Zhang, Z. et al. Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K\/Akt\/mTOR pathway and remodeling choline metabolism. J. Nanobiotechnol. 21, 29 (2023).","journal-title":"J. Nanobiotechnol."},{"key":"31169_CR14","doi-asserted-by":"publisher","first-page":"2000515","DOI":"10.1002\/advs.202000515","volume":"7","author":"Q Lv","year":"2020","unstructured":"Lv, Q. et al. Thermosensitive exosome\u2013liposome hybrid nanoparticle-mediated chemoimmunotherapy for improved treatment of metastatic peritoneal cancer. Adv. Sci. 7, 2000515 (2020).","journal-title":"Adv. Sci."},{"key":"31169_CR15","doi-asserted-by":"publisher","first-page":"121244","DOI":"10.1016\/j.ijpharm.2021.121244","volume":"610","author":"H Abbas","year":"2021","unstructured":"Abbas, H. et al. Superparamagnetic iron oxide loaded Chitosan coated bilosomes for magnetic nose to brain targeting of Resveratrol. Int. J. Pharm. 610, 121244 (2021).","journal-title":"Int. J. Pharm."},{"key":"31169_CR16","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1080\/19390211.2016.1207003","volume":"14","author":"AU Cach\u00f3n","year":"2017","unstructured":"Cach\u00f3n, A. U., Quintal-Novelo, C., Medina-Escobedo, G., Castro-Aguilar, G. & Moo-Puc, R. E. Hepatoprotective effect of low doses of caffeine on CCl4-Induced liver damage in rats. J. Diet. Suppl. 14, 158\u2013172 (2017).","journal-title":"J. Diet. Suppl."},{"key":"31169_CR17","doi-asserted-by":"publisher","first-page":"111989","DOI":"10.1016\/j.biopha.2021.111989","volume":"142","author":"M Yamaguchi","year":"2021","unstructured":"Yamaguchi, M., Dohi, N., Ooka, A., Saito, S. & Ishikawa, T. Caffeine-induced inversion of prostaglandin E2 effects on hepatic stellate cell activation. Biomed. Pharmacother. 142, 111989 (2021).","journal-title":"Biomed. Pharmacother"},{"key":"31169_CR18","doi-asserted-by":"publisher","first-page":"2409","DOI":"10.3390\/nu13072409","volume":"13","author":"EG Kov\u00e1cs","year":"2021","unstructured":"Kov\u00e1cs, E. G. et al. Caffeine has different Immunomodulatory effect on the cytokine expression and NLRP3 inflammasome function in various human macrophage subpopulations. Nutrients 13, 2409 (2021).","journal-title":"Nutrients"},{"key":"31169_CR19","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.3390\/ijms23179954","volume":"23","author":"EE Vargas-Pozada","year":"2022","unstructured":"Vargas-Pozada, E. E. et al. Caffeine inhibits NLRP3 inflammasome activation by downregulating TLR4\/MAPK\/NF-\u03baB signaling pathway in an experimental NASH model. Int. J. Mol. Sci. 23, 9954 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"31169_CR20","first-page":"82","volume":"3","author":"M Mohamed","year":"2013","unstructured":"Mohamed, M., Makky, A. & Abdellatif, M. Liposomal gels as carriers for safer topical delivery of Tazarotene. J. Pharm. Res. Opin. 3, 82\u201390 (2013).","journal-title":"J. Pharm. Res. Opin."},{"issue":"1","key":"31169_CR21","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1080\/10717544.2020.1837295","volume":"27","author":"R Albash","year":"2020","unstructured":"Albash, R., Elmahboub, Y., Baraka, K., Abdellatif, M. M. & Alaa-Eldin, A. A. Ultra-deformable liposomes containing terpenes (terpesomes) loaded fenticonazole nitrate for treatment of vaginal candidiasis: Box-Behnken design optimization, comparative ex vivo and in vivo studies. Drug Deliv. 27 (1), 1514\u20131523 (2020).","journal-title":"Drug Deliv"},{"issue":"8","key":"31169_CR22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.2217\/nnm.10.84","volume":"5","author":"E Gultepe","year":"2010","unstructured":"Gultepe, E. et al. Monitoring of magnetic targeting to tumor vasculature through MRI and biodistribution. Nanomedicine 5 (8), 1173\u20131182 (2010).","journal-title":"Nanomedicine"},{"issue":"8","key":"31169_CR23","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/ijms17081209","volume":"17","author":"R Mart\u00ednez-Gonz\u00e1lez","year":"2016","unstructured":"Mart\u00ednez-Gonz\u00e1lez, R., Estelrich, J. & Busquets, M. A. Liposomes loaded with hydrophobic iron oxide nanoparticles: suitable T2 contrast agents for MRI. Int. J. Mol. Sci. 17 (8), 1209 (2016).","journal-title":"Int. J. Mol. Sci."},{"key":"31169_CR24","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13346-019-00706-2","volume":"11","author":"NF Younes","year":"2021","unstructured":"Younes, N. F., El Assasy, A. E. H. I. & Makhlouf, A. I. A. Microenvironmental pH-modified Amisulpride-Labrasol matrix tablets: development, optimization and in vivo pharmacokinetic study. Drug Delivery Transl. Res. 11, 103\u2013117 (2021).","journal-title":"Drug Delivery Transl. Res."},{"key":"31169_CR25","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00580-019-03008-8","volume":"28","author":"SY Sayed","year":"2019","unstructured":"Sayed, S. Y., Salem, S. I., Abdallah, A. N., Khalil, G. M. & Mohammed, F. F. Clinicopathological studies on the use of laser-activated adipose-derived stromal vascular fraction in treatment of streptozotocin-induced diabetes in rats. Comp. Clin. Path. 28, 1515\u20131526 (2019).","journal-title":"Comp. Clin. Path"},{"key":"31169_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s12291-017-0641-x","volume":"33","author":"H Ghaneialvar","year":"2018","unstructured":"Ghaneialvar, H., Soltani, L., Rahmani, H. R., Lotfi, A. S. & Soleimani, M. Characterization and classification of mesenchymal stem cells in several species using surface markers for cell therapy purposes. Indian J. Clin. Biochem. 33, 46\u201352 (2018).","journal-title":"Indian J. Clin. Biochem."},{"key":"31169_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s12917-024-03920-4","volume":"20","author":"AN Abdallah","year":"2024","unstructured":"Abdallah, A. N., Shamaa, A. A., El-Tookhy, O. S. & Bahr, M. M. Comparison between stem cell therapy and stem cell derived exosomes on induced multiple sclerosis in dogs. BMC Vet. Res. 20, 90 (2024).","journal-title":"BMC Vet. Res."},{"key":"31169_CR28","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3389\/fimmu.2014.00525","volume":"5","author":"M Franquesa","year":"2014","unstructured":"Franquesa, M. et al. Update on controls for isolation and quantification methodology of extracellular vesicles derived from adipose tissue mesenchymal stem cells. Front. Immunol. 5, 525 (2014).","journal-title":"Front. Immunol."},{"key":"31169_CR29","doi-asserted-by":"publisher","first-page":"10964","DOI":"10.1038\/s41598-024-59736-7","volume":"14","author":"AH Farouk","year":"2024","unstructured":"Farouk, A. H., Aref, A., Fathy, B. A. & Abdallah, A. N. Stem cells derived exosomes as biological nano carriers for VCR sulfate for treating breast cancer stem cells. Sci. Rep. 14, 10964 (2024).","journal-title":"Sci. Rep."},{"issue":"6","key":"31169_CR30","doi-asserted-by":"publisher","first-page":"102096","DOI":"10.1016\/j.jsps.2024.102096","volume":"32","author":"R Gul","year":"2024","unstructured":"Gul, R. et al. Human plasma derived exosomes: impact of active and passive drug loading approaches on drug delivery. Saudi Pharm. J. 32 (6), 102096 (2024).","journal-title":"Saudi Pharm. J."},{"key":"31169_CR31","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s11010-022-04508-y","volume":"478","author":"Q Chen","year":"2023","unstructured":"Chen, Q. et al. Anti-inflammatory effects of extracellular vesicles from Morchella on LPS-stimulated RAW264.7 cells via the ROS-mediated p38 MAPK signaling pathway. Mol. Cell. Biochem. 478, 317\u2013327 (2023).","journal-title":"Mol. Cell. Biochem."},{"key":"31169_CR32","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1039\/D1BM01663F","volume":"10","author":"K Ji","year":"2022","unstructured":"Ji, K. et al. Clodronate-nintedanib-loaded exosome\u2013liposome hybridization enhances the liver fibrosis therapy by inhibiting Kupffer cell activity. Biomaterials Sci. 10, 702\u2013713 (2022).","journal-title":"Biomaterials Sci."},{"key":"31169_CR33","doi-asserted-by":"publisher","first-page":"100671","DOI":"10.1016\/j.aohep.2022.100671","volume":"27","author":"EE Vargas-Pozada","year":"2022","unstructured":"Vargas-Pozada, E. E. et al. Caffeine mitigates experimental nonalcoholic steatohepatitis and the progression of thioacetamide-induced liver fibrosis by blocking the MAPK and TGF-\u03b2\/Smad3 signaling pathways. Ann. Hepatol. 27, 100671 (2022).","journal-title":"Ann. Hepatol."},{"key":"31169_CR34","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3390\/antiox11112152","volume":"11","author":"MA ElBaset","year":"2022","unstructured":"ElBaset, M. A. et al. Effect of empagliflozin on Thioacetamide-Induced liver injury in rats: role of AMPK\/SIRT-1\/HIF-1\u03b1 pathway in halting liver fibrosis. Antioxidants 11, 2152 (2022).","journal-title":"Antioxidants"},{"issue":"2","key":"31169_CR35","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/antiox10020251","volume":"10","author":"ZA Othman","year":"2021","unstructured":"Othman, Z. A., Zakaria, Z., Suleiman, J. B., Ghazali, W. S. W. & Mohamed, M. Anti-Atherogenic effects of Orlistat on Obesity-Induced vascular oxidative stress rat model. Antioxidants 10 (2), 251 (2021).","journal-title":"Antioxidants"},{"key":"31169_CR36","doi-asserted-by":"publisher","first-page":"e16150553","DOI":"10.1590\/1678-4324-2016150553","volume":"59","author":"NM Al-Rasheed","year":"2016","unstructured":"Al-Rasheed, N. M., Fadda, L. M., Al-Rasheed, N. M., Ali, H. M. & Yacoub, H. I. Down-regulation of NFKB, Bax, TGF-\u03b2, Smad-2mRNA expression in the livers of carbon tetrachloride treated rats using different natural antioxidants. Brazilian Archives Biology Technol. 59, e16150553 (2016).","journal-title":"Brazilian Archives Biology Technol."},{"key":"31169_CR37","doi-asserted-by":"crossref","first-page":"3376","DOI":"10.3892\/etm.2018.6025","volume":"15","author":"S Zhou","year":"2018","unstructured":"Zhou, S., Wang, G. & Zhang, W. Effect of TLR4\/MyD88 signaling pathway on sepsis-associated acute respiratory distress syndrome in rats, via regulation of macrophage activation and inflammatory response. Exp. Ther. Med. 15, 3376\u20133384 (2018).","journal-title":"Exp. Ther. Med."},{"key":"31169_CR38","doi-asserted-by":"publisher","first-page":"3342","DOI":"10.3748\/wjg.v13.i24.3342","volume":"13","author":"X-H Wu","year":"2007","unstructured":"Wu, X-H. et al. Reversal of hyperglycemia in diabetic rats by portal vein transplantation of islet-like cells generated from bone marrow mesenchymal stem cells. World J. Gastroenterology: WJG. 13, 3342 (2007).","journal-title":"World J. Gastroenterology: WJG"},{"key":"31169_CR39","volume-title":"Bancroft\u2019s Theory and Practice of Histological Techniques","author":"KS Suvarna","year":"2018","unstructured":"Suvarna, K. S., Layton, C. & Bancroft, J. D. Bancroft\u2019s Theory and Practice of Histological Techniques (Elsevier health sciences, 2018)."},{"key":"31169_CR40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejps.2016.12.005","volume":"99","author":"AA Kassem","year":"2017","unstructured":"Kassem, A. A., Abd El-Alim, S. H., Basha, M. & Salama, A. Phospholipid complex enriched micelles: A novel drug delivery approach for promoting the antidiabetic effect of repaglinide. Eur. J. Pharm. Sci. 99, 75\u201384 (2017).","journal-title":"Eur. J. Pharm. Sci."},{"key":"31169_CR41","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/521951","volume":"2013","author":"K Rajam","year":"2013","unstructured":"Rajam, K., Rajendran, S. & Banu, N. N. Effect of caffeine-Zn2 + system in preventing corrosion of carbon steel in well water. J. Chem. 2013, 521951 (2013).","journal-title":"J. Chem."},{"key":"31169_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/scipharm91010001","volume":"91","author":"MM Abdellatif","year":"2023","unstructured":"Abdellatif, M. M., Ahmed, S. M., El-Nabarawi, M. A. & Teaima, M. Oral bioavailability enhancement of Vancomycin hydrochloride with cationic nanocarrier (Leciplex): Optimization, in Vitro, ex vivo, and in vivo studies. Sci. Pharm. 91, 1 (2023).","journal-title":"Sci. Pharm."},{"key":"31169_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3390\/ddc2010006","volume":"2","author":"J Vassoudevane","year":"2023","unstructured":"Vassoudevane, J., Mariebernard, M. & Rajendran, V. Stearylamine liposome as an anti-parasitic agent. Drugs Drug Candidates. 2, 95\u2013108 (2023).","journal-title":"Drugs Drug Candidates"},{"key":"31169_CR44","doi-asserted-by":"publisher","first-page":"251","DOI":"10.5650\/jos.54.251","volume":"54","author":"S Yokoyama","year":"2005","unstructured":"Yokoyama, S. et al. Stearylamine changes the liposomal shape from MLVs to LUVs. J. Oleo Sci. 54, 251\u2013254 (2005).","journal-title":"J. Oleo Sci."},{"key":"31169_CR45","doi-asserted-by":"publisher","first-page":"126973","DOI":"10.1016\/j.foodchem.2020.126973","volume":"326","author":"K Tai","year":"2020","unstructured":"Tai, K., Rappolt, M., Mao, L., Gao, Y. & Yuan, F. Stability and release performance of curcumin-loaded liposomes with varying content of hydrogenated phospholipids. Food Chem. 326, 126973 (2020).","journal-title":"Food Chem."},{"key":"31169_CR46","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.3390\/pharmaceutics15071947","volume":"15","author":"A Kassem","year":"2023","unstructured":"Kassem, A., Refai, H., El-Nabarawi, M. A. & Abdellatif, M. M. Formulation and evaluation of prednisolone sodium Metazoate-Loaded mucoadhesive quatsomal gel for local treatment of recurrent aphthous ulcers: Optimization, in Vitro, ex vivo, and in vivo studies. Pharmaceutics 15, 1947 (2023).","journal-title":"Pharmaceutics"},{"key":"31169_CR47","doi-asserted-by":"publisher","first-page":"6758","DOI":"10.1016\/j.biomaterials.2012.05.026","volume":"33","author":"S Jain","year":"2012","unstructured":"Jain, S., Kumar, D., Swarnakar, N. K. & Thanki, K. Polyelectrolyte stabilized multilayered liposomes for oral delivery of Paclitaxel. Biomaterials 33, 6758\u20136768 (2012).","journal-title":"Biomaterials"},{"key":"31169_CR48","first-page":"2","volume":"7","author":"M Ghule","year":"2018","unstructured":"Ghule, M. & Bhoyar, G. Formulation and evaluation of modified liposome for transdermal drug. J. Developing Drugs. 7, 2\u20133 (2018).","journal-title":"J. Developing Drugs"},{"key":"31169_CR49","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jconrel.2024.02.022","volume":"368","author":"K Wang","year":"2024","unstructured":"Wang, K. et al. Engineered liposomes targeting hepatic stellate cells overcome pathological barriers and reverse liver fibrosis. J. Controlled Release. 368, 219\u2013232. https:\/\/doi.org\/10.1016\/j.jconrel.2024.02.022 (2024).","journal-title":"J. Controlled Release"},{"key":"31169_CR50","doi-asserted-by":"crossref","unstructured":"Toro-Cordova, A. et al. Liposomes loaded with cisplatin and magnetic nanoparticles: physicochemical characterization, pharmacokinetics, and in-vitro efficacy. Molecules 23, (2018).","DOI":"10.3390\/molecules23092272"},{"key":"31169_CR51","doi-asserted-by":"publisher","first-page":"20360","DOI":"10.3402\/jev.v2i0.20360","volume":"2","author":"KW Witwer","year":"2013","unstructured":"Witwer, K. W. et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J. Extracell. Vesicles. 2, 20360 (2013).","journal-title":"J. Extracell. Vesicles"},{"key":"31169_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.tjog.2014.04.005","volume":"53","author":"S-Y Peng","year":"2014","unstructured":"Peng, S-Y. et al. Therapeutic potential of amniotic-fluid-derived stem cells on liver fibrosis model in mice. Taiwan. J. Obstet. Gynecol. 53, 151\u2013157 (2014).","journal-title":"Taiwan. J. Obstet. Gynecol."},{"key":"31169_CR53","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/0300-483X(84)90154-9","volume":"31","author":"E Chieli","year":"1984","unstructured":"Chieli, E. & Malvaldi, G. Role of the microsomal fad-containing monooxygenase in the liver toxicity of thioacetamide S-oxide. Toxicology 31, 41\u201352 (1984).","journal-title":"Toxicology"},{"key":"31169_CR54","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0024-3205(97)01033-3","volume":"62","author":"MI Torres","year":"1997","unstructured":"Torres, M. I., Fern\u00e1ndez, M. I., Gil, A. & R\u00edos, A. Dietary nucleotides have cytoprotective properties in rat liver damaged by thioacetamide. Life Sci. 62, 13\u201322 (1997).","journal-title":"Life Sci."},{"key":"31169_CR55","first-page":"140","volume":"10","author":"S Bahashwan","year":"2015","unstructured":"Bahashwan, S. et al. Crocin mitigates carbon tetrachloride-induced liver toxicity in rats. J. Taibah Univ. Med. Sci. 10, 140\u2013149 (2015).","journal-title":"J. Taibah Univ. Med. Sci."},{"key":"31169_CR56","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1080\/01926230590881808","volume":"33","author":"HM Mehendale","year":"2005","unstructured":"Mehendale, H. M. Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol. Pathol. 33, 41\u201351 (2005).","journal-title":"Toxicol. Pathol."},{"key":"31169_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.biopha.2018.02.064","volume":"101","author":"SM Eraky","year":"2018","unstructured":"ErakySM, El-MeseryM, El-KarefA, EissaLA & El-GayarAM Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression. Biomed. Pharmacother. 101, 49\u201357 (2018).","journal-title":"Biomed. Pharmacother"},{"key":"31169_CR58","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41575-020-00372-7","volume":"18","author":"T Kisseleva","year":"2021","unstructured":"Kisseleva, T. & Brenner, D. Molecular and cellular mechanisms of liver fibrosis and its regression. Nat. Reviews Gastroenterol. Hepatol. 18, 151\u2013166 (2021).","journal-title":"Nat. Reviews Gastroenterol. Hepatol."},{"key":"31169_CR59","doi-asserted-by":"crossref","unstructured":"El-Gendy, Z. A. et al. Hepatoprotective effect of Saccharomyces cervisciae cell wall extract against thioacetamide-induced liver fibrosis in rats. Heliyon 7\u00a0(2021).","DOI":"10.1016\/j.heliyon.2021.e07159"},{"key":"31169_CR60","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.3390\/cells8111419","volume":"8","author":"B Dewidar","year":"2019","unstructured":"Dewidar, B., Meyer, C., Dooley, S. & Meindl-Beinker Nadja. TGF-\u03b2 in hepatic stellate cell activation and liver Fibrogenesis\u2014Updated 2019. Cells 8, 1419 (2019).","journal-title":"Cells"},{"key":"31169_CR61","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.3390\/molecules26071937","volume":"26","author":"M-Y Tsai","year":"2021","unstructured":"Tsai, M-Y. et al. The ameliorative effects of fucoidan in Thioacetaide-Induced liver injury in mice. Molecules 26, 1937 (2021).","journal-title":"Molecules"},{"key":"31169_CR62","doi-asserted-by":"publisher","first-page":"3927","DOI":"10.3892\/ol.2017.6668","volume":"14","author":"M Glover","year":"2017","unstructured":"Glover, M. et al. Influence of chronic inflammation on Bcl\u20132 and PCNA expression in prostate needle biopsy specimens. Oncol. Lett. 14, 3927\u20133934 (2017).","journal-title":"Oncol. Lett."},{"key":"31169_CR63","doi-asserted-by":"publisher","first-page":"eaau6977","DOI":"10.1126\/science.aau6977","volume":"367","author":"R Kalluri","year":"2020","unstructured":"Kalluri, R. & LeBleu, V. S. The biology, function, and biomedical applications of exosomes. Science 367, eaau6977 (2020).","journal-title":"Science"},{"key":"31169_CR64","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13578-023-01122-3","volume":"13","author":"Q Huai","year":"2023","unstructured":"Huai, Q. et al. Mesenchymal stromal\/stem cells and their extracellular vesicles in liver diseases: insights on their Immunomodulatory roles and clinical applications. Cell. Biosci. 13, 162 (2023).","journal-title":"Cell. Biosci."},{"key":"31169_CR65","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.cell.2016.01.043","volume":"164","author":"M Tkach","year":"2016","unstructured":"Tkach, M. & Th\u00e9ry, C. Communication by extracellular vesicles: where we are and where we need to go. Cell 164, 1226\u20131232 (2016).","journal-title":"Cell"},{"key":"31169_CR66","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/cells8121605","volume":"8","author":"CR Harrell","year":"2019","unstructured":"Harrell, C. R., Jovicic, N., Djonov, V., Arsenijevic, N. & Volarevic, V. Mesenchymal stem Cell-Derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells 8, 1605 (2019).","journal-title":"Cells"},{"key":"31169_CR67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.2174\/1566523220666200916120708","volume":"20","author":"F Tavasolian","year":"2020","unstructured":"Tavasolian, F., Hosseini, A. Z., Soudi, S. & Naderi, M. miRNA-146a improves Immunomodulatory effects of MSC-derived exosomes in rheumatoid arthritis. Curr. Gene Ther. 20, 297\u2013312 (2020).","journal-title":"Curr. Gene Ther."},{"key":"31169_CR68","doi-asserted-by":"publisher","first-page":"624024","DOI":"10.3389\/fimmu.2021.624024","volume":"12","author":"Y-M Pers","year":"2021","unstructured":"Pers, Y-M. et al. miR-155 contributes to the immunoregulatory function of human mesenchymal stem cells. Front. Immunol. 12, 624024 (2021).","journal-title":"Front. Immunol."},{"key":"31169_CR69","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.intimp.2018.12.043","volume":"68","author":"H Wu","year":"2019","unstructured":"Wu, H. et al. Extracellular vesicles containing miR-146a attenuate experimental colitis by targeting TRAF6 and IRAK1. Int. Immunopharmacol. 68, 204\u2013212 (2019).","journal-title":"Int. Immunopharmacol."},{"key":"31169_CR70","first-page":"67","volume":"41","author":"J Joseph","year":"2020","unstructured":"Joseph, J. Serum marker panels for predicting liver Fibrosis - An update. Clin. Biochem. Rev. 41, 67\u201373 (2020).","journal-title":"Clin. Biochem. Rev."},{"key":"31169_CR71","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s13770-020-00267-3","volume":"17","author":"DM Rostom","year":"2020","unstructured":"Rostom, D. M., Attia, N., Khalifa, H. M., Abou Nazel, M. W. & El Sabaawy, E. A. The therapeutic potential of extracellular vesicles versus mesenchymal stem cells in liver damage. Tissue Eng. Regenerative Med. 17, 537\u2013552 (2020).","journal-title":"Tissue Eng. Regenerative Med."},{"key":"31169_CR72","doi-asserted-by":"publisher","first-page":"37421","DOI":"10.1021\/acsami.9b10126","volume":"11","author":"S Mardpour","year":"2019","unstructured":"Mardpour, S. et al. Hydrogel-Mediated sustained systemic delivery of mesenchymal stem Cell-Derived extracellular vesicles improves hepatic regeneration in chronic liver failure. ACS Appl. Mater. Interfaces. 11, 37421\u201337433 (2019).","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"31169_CR73","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/j.ymthe.2020.12.025","volume":"29","author":"J Kim","year":"2021","unstructured":"Kim, J. et al. sEVs from tonsil-derived mesenchymal stromal cells alleviate activation of hepatic stellate cells and liver fibrosis through miR-486-5p. Mol. Ther. 29, 1471\u20131486 (2021).","journal-title":"Mol. Ther."},{"key":"31169_CR74","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.3390\/ijms20102381","volume":"20","author":"M Tapparo","year":"2019","unstructured":"Tapparo, M. et al. Renal regenerative potential of extracellular vesicles derived from miRNA-Engineered mesenchymal stromal cells. Int. J. Mol. Sci. 20, 2381 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"31169_CR75","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/scrt465","volume":"5","author":"CY Tan","year":"2014","unstructured":"Tan, C. Y. et al. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell. Res. Ther. 5, 76 (2014).","journal-title":"Stem Cell. Res. Ther."},{"key":"31169_CR76","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1053\/j.gastro.2004.09.075","volume":"128","author":"CE Ruhl","year":"2005","unstructured":"Ruhl, C. E. & Everhart, J. E. Coffee and caffeine consumption reduce the risk of elevated serum Alanine aminotransferase activity in the united States. Gastroenterology 128, 24\u201332 (2005).","journal-title":"Gastroenterology"},{"key":"31169_CR77","first-page":"183","volume":"17","author":"A Rezaie","year":"2014","unstructured":"Rezaie, A. et al. Hepatoprotective effect of caffeine on diethylnitrosamine-induced liver injury in rats. Bulg. J. Vet. Med. 17, 183\u2013190 (2014).","journal-title":"Bulg. J. Vet. Med."},{"key":"31169_CR78","doi-asserted-by":"publisher","first-page":"9020","DOI":"10.3748\/wjg.v19.i47.9020","volume":"19","author":"D Gordillo-Bastidas","year":"2013","unstructured":"Gordillo-Bastidas, D. et al. Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine. World J. Gastroenterol. 19, 9020\u20139033 (2013).","journal-title":"World J. Gastroenterol."},{"key":"31169_CR79","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.3390\/antiox9121279","volume":"9","author":"E Ramos-Tovar","year":"2020","unstructured":"Ramos-Tovar, E. & Muriel, P. Molecular mechanisms that link oxidative Stress, Inflammation, and fibrosis in the liver. Antioxidants 9, 1279 (2020).","journal-title":"Antioxidants"},{"key":"31169_CR80","doi-asserted-by":"publisher","first-page":"109598","DOI":"10.1016\/j.foodhyd.2023.109598","volume":"149","author":"R Shaddel","year":"2024","unstructured":"Shaddel, R. & Rajabi-Moghaddam, S. Encapsulation of caffeine in chitosan-coated nanoliposomes and its application in drink formulation. Food Hydrocoll. 149, 109598 (2024).","journal-title":"Food Hydrocoll."},{"key":"31169_CR81","first-page":"4","volume":"6","author":"K Poelstra","year":"2011","unstructured":"Poelstra, K. & Schuppan, D. Targeted therapy of liver fibrosis\/cirrhosis and its complications. Nucleus (Calcutta). 6, 4 (2011).","journal-title":"Nucleus (Calcutta)"},{"key":"31169_CR82","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fimmu.2020.00218","volume":"11","author":"CI Colino","year":"2020","unstructured":"Colino, C. I., Lanao, J. M. & Gutierrez-Millan, C. Targeting of hepatic macrophages by therapeutic nanoparticles. Front. Immunol. 11, 218 (2020).","journal-title":"Front. Immunol."},{"issue":"1","key":"31169_CR83","doi-asserted-by":"publisher","first-page":"5358","DOI":"10.3402\/nano.v1i0.5358","volume":"1","author":"N Singh","year":"2010","unstructured":"Singh, N., Jenkins, G. J. S., Asadi, R. & Doak, S. H. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Reviews. 1 (1), 5358 (2010).","journal-title":"Nano Reviews"},{"issue":"32","key":"31169_CR84","doi-asserted-by":"publisher","first-page":"e202203875","DOI":"10.1002\/chem.202203875","volume":"29","author":"T Mokkawes","year":"2023","unstructured":"Mokkawes, T. & de Visser, S. P. Caffeine biodegradation by cytochrome P450 1A2. What determines the product distributions? Chemistry \u2013. Eur. J. 29 (32), e202203875 (2023).","journal-title":"Eur. J."},{"key":"31169_CR85","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","volume":"240","author":"Y-N Zhang","year":"2016","unstructured":"Zhang, Y-N., Poon, W., Tavares, A. J., McGilvray, I. D. & Chan, W. C. W. Nanoparticle\u2013liver interactions: cellular uptake and hepatobiliary elimination. J. Controlled Release. 240, 332\u2013348 (2016).","journal-title":"J. Controlled Release"},{"key":"31169_CR86","doi-asserted-by":"publisher","first-page":"102757","DOI":"10.1016\/j.cis.2022.102757","volume":"309","author":"M Dymek","year":"2022","unstructured":"Dymek, M. & Sikora, E. Liposomes as biocompatible and smart delivery systems \u2013 the current state. Adv. Colloid Interface Sci. 309, 102757 (2022).","journal-title":"Adv. Colloid Interface Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31169-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31169-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31169-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T17:41:14Z","timestamp":1781631674000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31169-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":86,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31169"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31169-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"30 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"During the preparation of this work, the author(s) did not use any AI and AI-assisted technologies in the writing process.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Generative AI and AI-assisted technologies in the writing process"}}],"article-number":"5349"}}